SFS
CSBR icon

Sowell Financial Services’s Champions Oncology CSBR Stock Holding History

Sowell Financial Services’s Portfolio CSBR Stock Details CSBR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-30
Closed – – 2461
2019
Q4 		$0 Hold
30
– – ﹤0.01% 2527
2019
Q3 		$0 Buy
+30
New +$195 ﹤0.01% 2396

Other funds holding CSBR

BPI
Battery Partners IX Boston, Massachusetts $22.4M AUM 27.71% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
CPA
Cowen Prime Advisors New York $290M AUM 57.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return
CCM
Cadence Capital Management Boston, Massachusetts $415M AUM 11.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Sowell Financial Services's CSBR Position: Q1 2020 in Review

Sowell Financial Services sold out of Champions Oncology (CSBR) in Q1 2020, closing a stake of 30 shares.

Sowell Financial Services first reported a position in CSBR in Q3 2019 and held it in 2 quarters. The position peaked at $0 in Q4 2019. 32 funds tracked by Wall St. Rank hold CSBR as of Q1 2020.

  • Sowell Financial Services reported no remaining Champions Oncology position as of Q1 2020 after selling out during the quarter.
  • Sowell Financial Services sold 30 Champions Oncology shares in Q1 2020.
  • Sowell Financial Services first reported a position in Champions Oncology in Q3 2019 and held it in 2 quarters.
  • Sowell Financial Services's Champions Oncology position peaked at $0 in Q4 2019.
  • 32 funds tracked by Wall St. Rank held Champions Oncology as of Q1 2020.

Based on Sowell Financial Services's 13F filing for Q1 2020, filed 12 May 2020.